Clinuvel Pharmaceuticals Limited (ASX:CUV)
11.10
+0.12 (1.09%)
May 13, 2025, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 549.11 million as of May 13, 2025. Its market cap has decreased by -27.23% in one year.
Market Cap
549.11M
Enterprise Value
351.60M
Revenue
91.02M
Ranking
n/a
PE Ratio
14.27
Stock Price
11.10
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 549.11M, an increase of 10,407.89%. That is a compound annual growth rate of 21.15%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 115.88B |
Pro Medicus | 26.29B |
Cochlear | 17.50B |
Sonic Healthcare | 12.87B |
Telix Pharmaceuticals | 9.06B |
Ramsay Health Care | 8.43B |
Ansell | 4.62B |
Regis Healthcare | 2.24B |